Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2010-02-05 PENDERGAST MARY K Director Grant or award · Option to Purchase Common Stock +3,500 3,500
2009-02-27 PENDERGAST MARY K Director Grant or award · Option to Purchase Common Stock +7,500 7,500
2008-06-04 PENDERGAST MARY K Director Grant or award · Non-Qualified Stock Option (right to buy) +15,000 15,000
2007-05-31 PENDERGAST MARY K Director Grant or award · Non-Qualified Stock Option (right to buy) +15,000 15,000

Page 1 of 1 · 4 trades